← Back to Clinical Trials
Recruiting NCT05836961

NCT05836961 Impact of Benazir Nashonuma Program (BNP) on Maternal and Child Nutritional Status

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05836961
Status Recruiting
Phase
Sponsor Aga Khan University
Condition Low Birthweight
Study Type INTERVENTIONAL
Enrollment 5,500 participants
Start Date 2023-02-01
Primary Completion 2025-09

Eligibility & Interventions

Sex Female only
Min Age 18 Years
Max Age 49 Years
Study Type INTERVENTIONAL
Interventions
Benazir Nashonuma Program (BNP)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 5,500 participants in total. It began in 2023-02-01 with a primary completion date of 2025-09.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The purpose of this study is to evaluate the impact of Benazir Nashonuma Program (BNP) which includes specialized nutritious food (SNF) augmented with specific reproductive health interventions during pregnancy on proportion of low birthweight babies and stunting among children, in low income setting of Pakistan. The study aims to answer if: 1. Utilization of Benazir Nashonuma Program (BNP) among pregnant women is effective in reducing the proportion of low birthweight babies, compared to pregnant women who are not utilizing the program, among low income setting population. 2. Utilization of Benazir Nashonuma Program (BNP) is effective in reducing the proportion of stunting among children, compared to those not utilizing the program, among low income setting population. Participants who are enrolled in the Benazir Nashonuma Program (receiving intervention) and those who are not enrolled (not receiving intervention) will be followed throughout pregnancy till delivery. After delivery mother-baby dyad will be followed for a period of 12 months. Compliance of supplementation will be measured, and outcomes (low birthweight and stunting) observed throughout the follow up.

Eligibility Criteria

Inclusion Criteria: Intervention arm: All pregnant women in their first or second trimester, who are enrolled in Benazir Nashonuma Program (BNP). Non-intervention arm: All pregnant women in their first or second trimester, who are not enrolled in Benazir Nashonuma Program (BNP). Exclusion Criteria: * Women who intend to migrate or relocate for more than 3 months during the study period will be excluded from the study. * Women in the non intervention group who are consuming specialized nutritious food (SNF) from any source at the time of enrollment will be excluded from the study.

Contact & Investigator

Central Contact

Dr Sajid Bashir Soofi

✉ sajid.soofi@aku.edu

📞 +923002769398

Frequently Asked Questions

Who can join the NCT05836961 clinical trial?

This trial is open to female participants only, aged 18 Years or older, up to 49 Years, studying Low Birthweight. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05836961 currently recruiting?

Yes, NCT05836961 is actively recruiting participants. Contact the research team at sajid.soofi@aku.edu for enrollment information.

Where is the NCT05836961 trial being conducted?

This trial is being conducted at Dadu, Pakistan.

Who is sponsoring the NCT05836961 clinical trial?

NCT05836961 is sponsored by Aga Khan University. The trial plans to enroll 5,500 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology